E-viri
Recenzirano
Odprti dostop
-
Rieber, Juliane; Streblow, Jan; Uhlmann, Lorenz; Flentje, Michael; Duma, Marciana; Ernst, Iris; Blanck, Oliver; Wittig, Andrea; Boda-Heggemann, Judit; Krempien, Robert; Lohaus, Fabian; Klass, Nathalie Desirée; Eble, Michael J; Imhoff, Detlef; Kahl, Henning; Petersen, Cordula; Gerum, Sabine; Henkenberens, Christoph; Adebahr, Sonja; Hass, Peter; Schrade, Elsge; Wendt, Thomas G; Hildebrandt, Guido; Andratschke, Nicolaus; Sterzing, Florian; Guckenberger, Matthias
Lung cancer (Amsterdam, Netherlands), 07/2016, Letnik: 97Journal Article
Highlights • SBRT for inoperable pulmonary metastases achieved excellent LC and promising OS. • LC was mainly influenced by BED at both isocenter and periphery. • Important prognostic factors were identified for selecting patients for SBRT treatment. • Important prognostic factors for OS were performance status, metastasis diameter and tumor histology. • OS was further significantly affected by number of metastases and time interval between primary tumor diagnosis and SBRT treatment.
